EcoDrugPlus

Mitogen-Activated Protein Kinase Kinase Kinase 9

Ensembl ID : ENSELUG00000020784
Gene Symbol: MAP3K9
3 Cross references
196 Possible Orthologues:

Monoglyceride Lipase

Ensembl ID : ENSELUG00000011798
Gene Symbol: MGLL
3 Cross references
209 Possible Orthologues:

Motilin Receptor

Ensembl ID : ENSELUG00000022884
Gene Symbol: MLNR
3 Cross references
172 Possible Orthologues:

Mu-Type Opioid Receptor

Ensembl ID : ENSELUG00000014278
Gene Symbol: LOC105021215
3 Cross references
215 Possible Orthologues:

Muscarinic Acetylcholine Receptor M5

Ensembl ID : ENSELUG00000019518
Gene Symbol: LOC105024354
3 Cross references
190 Possible Orthologues:

Muscarinic Acetylcholine Receptor M5-Like

Ensembl ID : ENSELUG00000005669
Gene Symbol: LOC105015670
3 Cross references
195 Possible Orthologues:

Natriuretic Peptide Receptor 2

Ensembl ID : ENSELUG00000012622
Gene Symbol: NPR2
2 Cross references
185 Possible Orthologues:

Natriuretic Peptide Receptor 3

Ensembl ID : ENSELUG00000022631
Gene Symbol: NPR3
3 Cross references
210 Possible Orthologues:

Neurogenic Locus Notch Homolog Protein 1

Ensembl ID : ENSELUG00000002143
Gene Symbol: LOC105014132
3 Cross references
200 Possible Orthologues:

Neurogenic Locus Notch Homolog Protein 1

Ensembl ID : ENSELUG00000001725
Gene Symbol: LOC105008094
3 Cross references
195 Possible Orthologues:

Neurogenic Locus Notch Homolog Protein 2

Ensembl ID : ENSELUG00000006223
Gene Symbol: LOC105011113
3 Cross references
189 Possible Orthologues:

Neuronal Acetylcholine Receptor Subunit Alpha-7

Ensembl ID : ENSELUG00000002869
Gene Symbol: LOC105008418
2 Cross references
186 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).